Business Description
Altimmune Inc
NAICS : 325412
SIC : 2834
ISIN : US02155H1014
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 329.75 | |||||
Equity-to-Asset | 0.92 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 16.24 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -70.7 | |||||
3-Year EBITDA Growth Rate | 7.8 | |||||
3-Year EPS without NRI Growth Rate | 9.3 | |||||
3-Year FCF Growth Rate | -1.8 | |||||
3-Year Book Growth Rate | -23.3 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 37.89 | |||||
9-Day RSI | 45.18 | |||||
14-Day RSI | 46.36 | |||||
6-1 Month Momentum % | 225.48 | |||||
12-1 Month Momentum % | 84.62 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 16.55 | |||||
Quick Ratio | 16.55 | |||||
Cash Ratio | 16.06 | |||||
Days Sales Outstanding | 477.53 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -23.9 | |||||
Shareholder Yield % | -16.49 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -21596.34 | |||||
Net Margin % | -22626.1 | |||||
FCF Margin % | -17523.96 | |||||
ROE % | -54.38 | |||||
ROA % | -49.56 | |||||
ROIC % | -963.24 | |||||
ROC (Joel Greenblatt) % | -12046.38 | |||||
ROCE % | -53.04 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 923.75 | |||||
PB Ratio | 3.03 | |||||
Price-to-Tangible-Book | 3.02 | |||||
EV-to-EBIT | -3.69 | |||||
EV-to-EBITDA | -3.77 | |||||
EV-to-Forward-EBITDA | -3.9 | |||||
EV-to-Revenue | 835.35 | |||||
EV-to-Forward-Revenue | 11.45 | |||||
EV-to-FCF | -4.71 | |||||
Price-to-Net-Current-Asset-Value | 3.04 | |||||
Price-to-Net-Cash | 3.15 | |||||
Earnings Yield (Greenblatt) % | -27.1 | |||||
FCF Yield % | -13.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Altimmune Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.384 | ||
EPS (TTM) (€) | -1.487 | ||
Beta | 1.18 | ||
Volatility % | 283.58 | ||
14-Day RSI | 46.36 | ||
14-Day ATR (€) | 0.411938 | ||
20-Day SMA (€) | 6.93015 | ||
12-1 Month Momentum % | 84.62 | ||
52-Week Range (€) | 1.968 - 13.7 | ||
Shares Outstanding (Mil) | 70.9 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Altimmune Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Altimmune Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Altimmune Inc Frequently Asked Questions
What is Altimmune Inc(FRA:3G0)'s stock price today?
When is next earnings date of Altimmune Inc(FRA:3G0)?
Does Altimmune Inc(FRA:3G0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |